MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

We’ve all heard the sayings “in due time,” “trust the process,” and “God may not come when you want him, but he is always on time.” They are meant to help you learn to be patient and trust the ...

This collection on daily rhythms and energy metabolism invites research integrating the disciplines of sleep and circadian biology with exercise physiology. Congratulations to Tjale Schütz (University ...

MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...

The Box Content Preview library allows developers to easily embed high quality and interactive previews of Box files in desktop and mobile web applications. The JavaScript library fetches information ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.